Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation.
Kyeryoung LeeZongzhi Z LiuYun MaiTomi JunMeng MaTongyu WangLei AiEdiz S CalayWilliam K OhGustavo StolovitzkyEric E SchadtXiaoyan WangPublished in: JMIR AI (2024)
Our customized NLP pipeline successfully generated a standardized eligibility criteria knowledge base by transforming hypernym criteria into machine-readable hyponyms along with their corresponding values. A prototype interface integrating real-world patient information allows us to assess the impact of each eligibility criterion on the number of patients eligible for the trial. Leveraging NLP and real-world data in a data-driven approach holds promise for streamlining the overall clinical trial process, optimizing processes, and improving efficiency in patient identification.
Keyphrases
- clinical trial
- phase ii
- end stage renal disease
- phase iii
- big data
- study protocol
- case report
- electronic health record
- ejection fraction
- deep learning
- newly diagnosed
- healthcare
- chronic kidney disease
- open label
- machine learning
- double blind
- randomized controlled trial
- prognostic factors
- peritoneal dialysis
- autism spectrum disorder
- patient reported outcomes
- health information
- artificial intelligence
- placebo controlled
- data analysis